Literature DB >> 18211901

SUMOylation modulates the transcription repressor function of RIP140.

Miia M Rytinki1, Jorma J Palvimo.   

Abstract

RIP140/NRIP1 (receptor-interacting protein 140) functions as a corepressor of nuclear receptors. It plays an important role in the transcriptional control of energy metabolism and female fertility. RIP140 contains four distinct repression domains (RD1-RD4), and the repressive activity of RIP140 involves complex mechanisms. The function of both RD1 and RD2 is linked to recruitment of histone deacetylases and C-terminal binding protein, respectively, but the mechanism of repression for RD3 and RD4 has remained elusive. Because covalent modification by small ubiquitin-like modifiers (SUMO-1, -2, and -3; SUMOylation) is often associated with transcriptional repression, we studied whether SUMOylation is involved in the repressive activity of RIP140. We show that two conserved lysines, Lys(756) and Lys(1154), located in RD3 and RD4, respectively, are subject to reversible SUMOylation, with SUMO-1 being more efficiently conjugated than SUMO-2. Interestingly, mutations of the RIP140 SUMOylation sites compromised the transcription repressor function of RIP140 and blunted its capacity to repress estrogen receptor alpha-dependent transcription. Conjugation of SUMO-1 also influenced the subnuclear distribution pattern of RIP140. In sum, our demonstration that the function of RIP140 repression domains 3 and 4 can be modulated by reversible SUMO modification thus adds a novel level to the regulation of RIP140 activity, which may have ramifications in the control of gene networks exerted by RIP140.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18211901     DOI: 10.1074/jbc.M709359200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Downregulation of RIP140 in hepatocellular carcinoma promoted the growth and migration of the cancer cells.

Authors:  Dexiang Zhang; Yueqi Wang; Yuedi Dai; Jiwen Wang; Tao Suo; Hongtao Pan; Han Liu; Sheng Shen; Houbao Liu
Journal:  Tumour Biol       Date:  2014-11-13

2.  Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.

Authors:  Zeynep Madak-Erdogan; Benita S Katzenellenbogen
Journal:  Toxicol Sci       Date:  2011-11-09       Impact factor: 4.849

3.  Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.

Authors:  Xavier H Mascle; Mathieu Lussier-Price; Laurent Cappadocia; Patricia Estephan; Luca Raiola; James G Omichinski; Muriel Aubry
Journal:  J Biol Chem       Date:  2013-10-30       Impact factor: 5.157

4.  Gene repressive activity of RIP140 through direct interaction with CDK8.

Authors:  Shawna D Persaud; Wei-Hong Huang; Sung Wook Park; Li-Na Wei
Journal:  Mol Endocrinol       Date:  2011-08-25

5.  Role of SUMOylation in full antiestrogenicity.

Authors:  Khalid Hilmi; Nader Hussein; Rodrigo Mendoza-Sanchez; Mohamed El-Ezzy; Houssam Ismail; Chantal Durette; Martine Bail; Maria Johanna Rozendaal; Michel Bouvier; Pierre Thibault; James L Gleason; Sylvie Mader
Journal:  Mol Cell Biol       Date:  2012-07-23       Impact factor: 4.272

Review 6.  PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity.

Authors:  Vitor A Lira; Carley R Benton; Zhen Yan; Arend Bonen
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-04-06       Impact factor: 4.310

7.  Thyroid hormone receptor isoform-specific modification by small ubiquitin-like modifier (SUMO) modulates thyroid hormone-dependent gene regulation.

Authors:  Yan-Yun Liu; Takahiko Kogai; James J Schultz; Kaizeen Mody; Gregory A Brent
Journal:  J Biol Chem       Date:  2012-08-28       Impact factor: 5.157

8.  Dynamic SUMOylation is linked to the activity cycles of androgen receptor in the cell nucleus.

Authors:  Miia Rytinki; Sanna Kaikkonen; Päivi Sutinen; Ville Paakinaho; Vesa Rahkama; Jorma J Palvimo
Journal:  Mol Cell Biol       Date:  2012-08-13       Impact factor: 4.272

9.  SUMOylation attenuates the function of PGC-1alpha.

Authors:  Miia M Rytinki; Jorma J Palvimo
Journal:  J Biol Chem       Date:  2009-07-22       Impact factor: 5.157

10.  SUMOylation inhibits SF-1 activity by reducing CDK7-mediated serine 203 phosphorylation.

Authors:  Wei-Hsiung Yang; Joanne H Heaton; Holly Brevig; Sarmistha Mukherjee; Jorge A Iñiguez-Lluhí; Gary D Hammer
Journal:  Mol Cell Biol       Date:  2008-11-17       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.